{"SPADE_N_07178": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07178", "Peptide Name": "C16S", "Source": "Laminin", "Family": "", "Gene": "Not found", "Sequence": "DFKLFAVTIKYR", "Sequence Length": 12, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "αvβ3, α5β1", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C73H113N17O17", "Mass": 1500.78, "PI": 9.7, "Net Charge": 2, "Hydrophobicity": 0.17, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:>10 hour", "Literature": [{"Title": "Anti-angiogenic peptides for cancer therapeutics", "Pubmed ID": "21470139", "Reference": "Curr Pharm Biotechnol. 2011 Aug;12(8)1101-19.", "Author": "Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21470139"}], "Frequent Amino Acids": "FKA", "Absent Amino Acids": "CEGHMNOPQSUW", "Basic Residues": 3, "Acidic Residues": 1, "Hydrophobic Residues": 7, "Polar Residues": 7, "Positive Residues": 3, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07179", "Similarity": 0.9166666666666666, "Sequence": "DFKLFAVYIKYR"}, {"SPADE_ID": "SPADE_N_14482", "Similarity": 0.8, "Sequence": "FLSGIVGMLFKLF"}, {"SPADE_ID": "SPADE_UN_26576", "Similarity": 0.8, "Sequence": "FLSGIVGMLFKLF"}]}}}